Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.
2.

Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells.

Lai MW, Chen TC, Pang ST, Yeh CT.

Urol Oncol. 2012 Nov-Dec;30(6):871-8. doi: 10.1016/j.urolonc.2010.09.010. Epub 2011 Mar 10.

PMID:
21396835
3.

Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo.

Cho SJ, Lee SS, Kim YJ, Park BD, Choi JS, Liu L, Ham YM, Moon Kim B, Lee SK.

Cancer Lett. 2010 Jan 28;287(2):196-206. doi: 10.1016/j.canlet.2009.06.011. Epub 2009 Jul 17.

PMID:
19616371
4.

KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway.

Li H, Jiang X, Yu Y, Huang W, Xing H, Agar NY, Yang HW, Yang B, Carroll RS, Johnson MD.

Oncogene. 2015 Mar 12;34(11):1432-41. doi: 10.1038/onc.2014.49. Epub 2014 Apr 7.

PMID:
24704824
5.

Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.

Yeh CT, Lu SC, Chen TC, Peng CY, Liaw YF.

Cancer Res. 2000 Sep 1;60(17):4697-700.

6.

Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.

Xing C, Xie H, Zhou L, Zhou W, Zhang W, Ding S, Wei B, Yu X, Su R, Zheng S.

Biochem Biophys Res Commun. 2012 Mar 30;420(1):29-35. doi: 10.1016/j.bbrc.2012.02.107. Epub 2012 Feb 27.

PMID:
22390936
7.

Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.

Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T, Cao X.

Cancer Res. 2003 Dec 1;63(23):8323-9.

8.

P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma.

Fang ZP, Jiang BG, Gu XF, Zhao B, Ge RL, Zhang FB.

Acta Pharmacol Sin. 2014 Jan;35(1):82-8. doi: 10.1038/aps.2013.31. Epub 2013 May 20.

9.

Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant.

Yeh CT, Lu SC, Chao CH, Chao ML.

Biochem Biophys Res Commun. 2003 May 30;305(2):311-4.

PMID:
12745075
10.
11.

Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.

Yue X, Zhang Z, Liang X, Gao L, Zhang X, Zhao D, Liu X, Ma H, Guo M, Spear BT, Gong Y, Ma C.

Gastroenterology. 2012 Jun;142(7):1559-70.e2. doi: 10.1053/j.gastro.2012.02.049. Epub 2012 Mar 6.

12.

The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.

Chiu CY, Kuo KK, Kuo TL, Lee KT, Cheng KH.

Mol Cancer Res. 2012 Mar;10(3):415-27. doi: 10.1158/1541-7786.MCR-11-0293. Epub 2012 Jan 12.

13.

MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.

Wan C, Hou S, Ni R, Lv L, Ding Z, Huang X, Hang Q, He S, Wang Y, Cheng C, Gu XX, Xu G, Shen A.

Oncogene. 2015 Jan 8;34(2):237-45. doi: 10.1038/onc.2013.536. Epub 2013 Dec 16.

PMID:
24336329
14.

Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.

Wong CC, Wong CM, Tung EK, Man K, Ng IO.

Hepatology. 2009 May;49(5):1583-94. doi: 10.1002/hep.22836.

PMID:
19205033
15.

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.

Mok WC, Wasser S, Tan T, Lim SG.

World J Gastroenterol. 2012 Jul 21;18(27):3527-36. doi: 10.3748/wjg.v18.i27.3527.

16.

A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.

Chen Q, Chen K, Guo G, Li F, Chen C, Wang S, Nalepa G, Huang S, Chen JL.

PLoS One. 2014 Oct 31;9(10):e111611. doi: 10.1371/journal.pone.0111611. eCollection 2014.

17.

RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma.

Deng Q, Li KY, Chen H, Dai JH, Zhai YY, Wang Q, Li N, Wang YP, Han ZG.

Hepatology. 2014 Feb;59(2):518-30. doi: 10.1002/hep.26665. Epub 2013 Dec 18.

PMID:
23929653
18.

Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.

Guo Y, Wang W, Wang J, Feng J, Wang Q, Jin J, Lv M, Li X, Li Y, Ma Y, Shen B, Zhang J.

Hepatology. 2013 Jan;57(1):140-51. doi: 10.1002/hep.25978.

PMID:
22903704
19.

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.

Gastroenterology. 2012 Sep;143(3):811-20.e1-15. doi: 10.1053/j.gastro.2012.05.033. Epub 2012 May 26.

PMID:
22641068
20.

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.

Xie C, Song LB, Wu JH, Li J, Yun JP, Lai JM, Xie DY, Lin BL, Yuan YF, Li M, Gao ZL.

PLoS One. 2012;7(7):e40607. doi: 10.1371/journal.pone.0040607. Epub 2012 Jul 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk